Latest Documents


  • 29-November-2013

    English

    Responsible Development of Nanotechnology

    This paper presents the findings of a survey of 25 countries. It provides a snapshot of current national or regional policy and research programmes designed to stimulate the growth of nanotechnology applications in diverse sectors of the economy while addressing the potential risks and the ethical and social challenges the technology might raise.

  • 7-November-2013

    English

    OECD/UNESCO Institute for Statistics/Eurostat Careers of Doctorate Holders (CDH) project

    This page presents the OECD statistical work on human resources in science and technology, more specifically the OECD/UNESCO Institute for Statistics/Eurostat project on careers of doctorate holders.

  • 2-August-2013

    English

    OECD work on patent statistics

    Patent indicators are used to map aspects of the innovative performance and technological progress of countries, regions or certain specific domains and technology fields.

    Related Documents
  • 20-June-2013

    English

    Unlocking Global Collaboration to Accelerate Innovation for Alzheimer's Disease and Dementia

    The aim of this consultation, held on 20-21 June 2013 in Oxford (UK), was to stimulate discussion at the highest possible level of expert engagement in setting out an agenda for OECD action to accelerate innovation for Alzheimer’s disease and dementia.

    Related Documents
  • 18-June-2013

    English

    Emerging Trends in Biomedicine and Health Technology Innovation: Addressing the Global Challenge of Alzheimer's

    The economic and social impact of chronic brain disorders such as Alzheimer’s and other neurodegenerative diseases will become the #1 public health problem worldwide by 2050, directly affecting 100 million people. Ongoing demographic trends, namely ageing populations, are leading to the unprecedented expansion of consumer demand for healthcare services, which will confront a serious crisis in a climate of shrinking resources.

  • 25-April-2013

    English

    Regulatory Frameworks for Nanotechnology in Foods and Medical Products: Summary Results of a Survey Activity

    Countries/regions have begun to develop and refine regulatory approaches for foods and medical products and invest in regulatory science and other research efforts to support the responsible development of nanotechnology in these areas. This paper inventories and analyses regulatory approaches, legislative regimes and government-sponsored research programmes and infrastructure in foods and medical products that involve nanotechnology.

  • 24-April-2013

    English

    Innovation in Southeast Asia

    The Southeast Asian (SEA) region is one of the most dynamic in the world. It is in a period of transition as its national economies become strongly integrated into global knowledge networks. Science and technology (S&T) offer opportunities for countries to ‘move up the value chain’. A better understanding of existing capabilities helps enhance mutually beneficial S&T and innovation co-operation between SEA and OECD

  • 16-April-2013

    English

    Launch of a new international collaboration on scientific collections: SciColl

    The April 2013 meeting of the OECD Global Forum saw the official launch of Scientific Collections International (SciColl), a new international network devoted to promoting interdisciplinary research that relies on scientific collections.

  • 15-March-2013

    English

    New Data for Understanding the Human Condition: International Perspectives

    OECD Global Science Forum report on data and research infrastructure for the social sciences.

  • 25-February-2013

    English

    OECD Recommendation on the Governance of Clinical Trials

    This framework introduces a risk-based oversight and management methodology for clinical trials. It combines a stratified approach that is based on the marketing authorisation status of the medical product and can be applied in a common manner across countries’ regulatory frameworks, with a trial-specific approach that considers other issues such as the type of populations concerned by the trial, or the informed consent of the patients.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 > >>